Search Results

You are looking at 1 - 5 of 5 items for :

  • Biochemistry x
Clear All
Open access

Christian Müller

-BNP Multicenter Study. J Am Coll Cardiol 2007: 1733-9. Epub 2007 Apr 2. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardio 2003; 41: 1264-72. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13. Christ-Crain M, Breidthardt T, Stolz D

Open access

Fatma Ucar, Gonul Erden, Mine Yavuz Taslipinar, Gulfer Ozturk, Zeynep Ginis, Erdem Bulut and Namik Delibas

: 540-8. 11. Felder RA, Boyd JC, Margrey K, Holman W, Savory J.Robotics in the medical laboratory. Clin Chem 1990; 36: 1534-43. 12. Markin RS, Whalen SA. Laboratory automation: trajectory, technology, and tactics. Clin Chem 2000; 46: 764-71. 13. Middleton SR. Developing an automation concept that is right for your laboratory. Clin Chem 2000; 46: 757-63. 14. Hawker CD, Garr SB, Hamilton LT, Penrose JR, Ashwood ER, Weiss RL. Automated transport and sorting system in a large reference laboratory: part 1

Open access

Gabriele Halwachs-Baumann

. Oppolzer EM, Müller MM. Health care system and laboratory medicine in Austria: present status and future perspectives. Clin Chim Acta 1999; 290: 37-55. Price CP, Barnes IC. Laboratory medicine in the United Kingdom: 1948-1998 and beyond. Clin Chim Acta 1999; 290: 5-36. Markin RS, Whalen SA. Laboratory automation: trajectory, technology, and tactics. Clin Chem 2000; 46: 764-71. Battisto DG. Hospital clinical laboratories are in a constant state of change. Clin Leadersh Manag Rev 2004; 18: 86

Open access

Sanja Stanković and Nada Majkić-Singh

al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 2008; 29: 1096-102. Dominguez-Rodriguez A, Samimi-Fard S, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kaski JC. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Am J Cardiol 2008; 101: 1537-40. Karadag B, Vatan B, Hacioglu Y, Duman D

Open access

Goran Koraćević, Vladan Ćosić and Ivana Stojanović

-reactive protein, and cause-specific mortality. Ann Epidemiol 2013; 23: 66-73. 71. Dokainish H, Pillai M, Murphy SA, et al.; TACTICS-TIMI-18 Investigators. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005; 45: 19-24. 72. Anderson JL, Adams CD, Antman EM, et al. ACC/ AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial in - farc tion: a report of the American